CSL (CSLLY) Net Change in Cash: $-644 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSLLY CSL Ltd CSLLY
63 GF Score
Price $30.10
GF Value $47.44
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is CSL Net Change in Cash?

CSL CSLLY -0.53% 63 Net Change in Cash is $-644 Mil as of Jun. 2026. GuruFocus rates CSLLY with a GF Score™ of 63/100 and a GF Value™ of $47.44 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

CSL's Net Change in Cash for the six months ended in Jun. 2026 was $368 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 was $-644 Mil.

CSL Net Change in Cash Historical Data

* Premium members only.

The historical data trend for CSL's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSL Net Change in Cash Chart

CSL Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,604.30 -8,825.00 134.00 514.00 -644.00

CSL Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Jun25 Dec25 Jun26
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -498.00 632.00 0.00 -1,012.00 368.00
CSLLY
63GF Score
CSL Ltd CSLLY
Net Change in Cash is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSL Net Change in Cash Calculation

CSL's Net Change in Cash for the fiscal year that ended in Jun. 2026 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=3512+-1271+-2828+-57
=-644

CSL's Net Change in Cash for the quarter that ended in Jun. 2026

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=2210+-619+-1185+-38
=368

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-644 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Change in Cash →
What does a Net Change in Cash of $-644 Mil mean?
CSL (CSLLY) has a Net Change in Cash of $-644 Mil as of Jun. 2026. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for CSL and its competitors.
Is CSL's Net Change in Cash too high?
CSL's current Net Change in Cash is $-644 Mil. Overall, CSL has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CSL's Net Change in Cash compare to VRTX and REGN?
CSL's Net Change in Cash of $-644 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Change in Cash for a Biotechnology company?
A good Net Change in Cash depends on the Biotechnology industry context. However, Net Change in Cash should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Change in Cash mean?
A high Net Change in Cash can signal that a stock is expensive relative to its fundamentals. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for CSL and its competitors. CSL's current Net Change in Cash is $-644 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSL stock overvalued right now?
Based on GuruFocus' analysis, CSL (CSLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $47.44, compared to a current price of $30.10 — trading 36.6% below its estimated fair value. The current Net Change in Cash is $-644 Mil. CSL's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Change in Cash calculated?
Net Change in Cash is calculated from a company's financial statements. For CSL (CSLLY), the current Net Change in Cash is $-644 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSL (CSLLY) Overvalued in 2026?

Based on GuruFocus' analysis, CSL stock appears to be undervalued. The current stock price of $30.10 is trading 36.6% below its estimated GF Value™ of $47.44. GuruFocus considers CSL to be Significantly Undervalued.

Key valuation signals for CSLLY:

  • Net Change in Cash: $-644 Mil
  • GF Value™: $47.44 vs. price of $30.10 (36.6% below fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the CSLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSL Business Description

Address 655 Elizabeth Street, Melbourne, VIC, AUS, 3000
CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
63GF Score

Get the complete analysis for CSLLY

Net Change in Cash is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.10
Price
$47.44
GF Value